Cargando…

Fusarium proliferatum-induced chronic lip ulcer: successful treatment with itraconazole: a case report

BACKGROUND: Fusarium species are saprophytic fungi with a worldwide distribution. These fungi cause various infections among immunocompromised patients; however, they can also involve immunocompetent individuals. CASE PRESENTATION: We report a case of a 41-year-old Iranian woman who presented with u...

Descripción completa

Detalles Bibliográficos
Autores principales: Mohaghegh, Fatemeh, Abtahi-Naeini, Bahareh, Nasri, Elahe, Badiee, Parisa, Morovati, Hamid, Fakhim, Hamed, Farmani, Aida, Meidani, Mohsen, Ranjbar-Mobarake, Maryam, Mohammadi, Rasoul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9523897/
https://www.ncbi.nlm.nih.gov/pubmed/36175913
http://dx.doi.org/10.1186/s13256-022-03575-5
_version_ 1784800388640145408
author Mohaghegh, Fatemeh
Abtahi-Naeini, Bahareh
Nasri, Elahe
Badiee, Parisa
Morovati, Hamid
Fakhim, Hamed
Farmani, Aida
Meidani, Mohsen
Ranjbar-Mobarake, Maryam
Mohammadi, Rasoul
author_facet Mohaghegh, Fatemeh
Abtahi-Naeini, Bahareh
Nasri, Elahe
Badiee, Parisa
Morovati, Hamid
Fakhim, Hamed
Farmani, Aida
Meidani, Mohsen
Ranjbar-Mobarake, Maryam
Mohammadi, Rasoul
author_sort Mohaghegh, Fatemeh
collection PubMed
description BACKGROUND: Fusarium species are saprophytic fungi with a worldwide distribution. These fungi cause various infections among immunocompromised patients; however, they can also involve immunocompetent individuals. CASE PRESENTATION: We report a case of a 41-year-old Iranian woman who presented with ulcerative lesions on her lips 10 months ago. She had a long history of anxiety but had no history of classical risk factors such as trauma, cosmetic lip tattoo, burning in her lips, smoking or use of alcohol and opium. A skin biopsy from the lower lip was performed and sent for microbiological examinations. Hyaline septate hyphae were seen on direct microscopy with potassium hydroxide. The clinical specimen was subcultured on sabouraud dextrose agar with chloramphenicol and prepared for antifungal susceptibility testing and molecular identification. Considering the minimum inhibitory concentrations (MIC) for antifungals, itraconazole (100 mg orally twice a day) was started for her, and after 2 months, the lesions were treated. She followed up for 3 months, and no signs of disease recurrence were observed. CONCLUSIONS: Selecting an appropriate treatment strategy according to the laboratory assessments is essential in clinical practice and the management of rare infections to prevent related mortality and morbidity of opportunistic fungal infections.
format Online
Article
Text
id pubmed-9523897
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-95238972022-10-01 Fusarium proliferatum-induced chronic lip ulcer: successful treatment with itraconazole: a case report Mohaghegh, Fatemeh Abtahi-Naeini, Bahareh Nasri, Elahe Badiee, Parisa Morovati, Hamid Fakhim, Hamed Farmani, Aida Meidani, Mohsen Ranjbar-Mobarake, Maryam Mohammadi, Rasoul J Med Case Rep Case Report BACKGROUND: Fusarium species are saprophytic fungi with a worldwide distribution. These fungi cause various infections among immunocompromised patients; however, they can also involve immunocompetent individuals. CASE PRESENTATION: We report a case of a 41-year-old Iranian woman who presented with ulcerative lesions on her lips 10 months ago. She had a long history of anxiety but had no history of classical risk factors such as trauma, cosmetic lip tattoo, burning in her lips, smoking or use of alcohol and opium. A skin biopsy from the lower lip was performed and sent for microbiological examinations. Hyaline septate hyphae were seen on direct microscopy with potassium hydroxide. The clinical specimen was subcultured on sabouraud dextrose agar with chloramphenicol and prepared for antifungal susceptibility testing and molecular identification. Considering the minimum inhibitory concentrations (MIC) for antifungals, itraconazole (100 mg orally twice a day) was started for her, and after 2 months, the lesions were treated. She followed up for 3 months, and no signs of disease recurrence were observed. CONCLUSIONS: Selecting an appropriate treatment strategy according to the laboratory assessments is essential in clinical practice and the management of rare infections to prevent related mortality and morbidity of opportunistic fungal infections. BioMed Central 2022-09-30 /pmc/articles/PMC9523897/ /pubmed/36175913 http://dx.doi.org/10.1186/s13256-022-03575-5 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Case Report
Mohaghegh, Fatemeh
Abtahi-Naeini, Bahareh
Nasri, Elahe
Badiee, Parisa
Morovati, Hamid
Fakhim, Hamed
Farmani, Aida
Meidani, Mohsen
Ranjbar-Mobarake, Maryam
Mohammadi, Rasoul
Fusarium proliferatum-induced chronic lip ulcer: successful treatment with itraconazole: a case report
title Fusarium proliferatum-induced chronic lip ulcer: successful treatment with itraconazole: a case report
title_full Fusarium proliferatum-induced chronic lip ulcer: successful treatment with itraconazole: a case report
title_fullStr Fusarium proliferatum-induced chronic lip ulcer: successful treatment with itraconazole: a case report
title_full_unstemmed Fusarium proliferatum-induced chronic lip ulcer: successful treatment with itraconazole: a case report
title_short Fusarium proliferatum-induced chronic lip ulcer: successful treatment with itraconazole: a case report
title_sort fusarium proliferatum-induced chronic lip ulcer: successful treatment with itraconazole: a case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9523897/
https://www.ncbi.nlm.nih.gov/pubmed/36175913
http://dx.doi.org/10.1186/s13256-022-03575-5
work_keys_str_mv AT mohagheghfatemeh fusariumproliferatuminducedchroniclipulcersuccessfultreatmentwithitraconazoleacasereport
AT abtahinaeinibahareh fusariumproliferatuminducedchroniclipulcersuccessfultreatmentwithitraconazoleacasereport
AT nasrielahe fusariumproliferatuminducedchroniclipulcersuccessfultreatmentwithitraconazoleacasereport
AT badieeparisa fusariumproliferatuminducedchroniclipulcersuccessfultreatmentwithitraconazoleacasereport
AT morovatihamid fusariumproliferatuminducedchroniclipulcersuccessfultreatmentwithitraconazoleacasereport
AT fakhimhamed fusariumproliferatuminducedchroniclipulcersuccessfultreatmentwithitraconazoleacasereport
AT farmaniaida fusariumproliferatuminducedchroniclipulcersuccessfultreatmentwithitraconazoleacasereport
AT meidanimohsen fusariumproliferatuminducedchroniclipulcersuccessfultreatmentwithitraconazoleacasereport
AT ranjbarmobarakemaryam fusariumproliferatuminducedchroniclipulcersuccessfultreatmentwithitraconazoleacasereport
AT mohammadirasoul fusariumproliferatuminducedchroniclipulcersuccessfultreatmentwithitraconazoleacasereport